Ifosfamide nephrotoxicity: Limited influence of metabolism and mode of administration during repeated therapy in paediatrics

This publication has 27 references indexed in Scilit:

• The kinetics of the auto-induction of ifosfamide metabolism during continuous infusion
  Cancer Chemotherapy and Pharmacology, 1995
• Comparison of continuous infusion and bolus administration of ifosfamide in children
  European Journal Of Cancer, 1995
• Identification of the major human hepatic cytochrome P450 involved in activation and N-dechloroethylation of ifosfamide
  Biochemical Pharmacology, 1994
• Molecular mechanisms of chloroacetaldehyde-induced cytotoxicity in isolated rat hepatocytes
  Biochemical Pharmacology, 1993
• Comparative pharmacokinetics of ifosfamide, 4-hydroxyifosfamide, chloroacetaldehyde, and 2- and 3-dechloroethylifosfamide in patients on fractionated intravenous ifosfamide therapy
  Cancer Chemotherapy and Pharmacology, 1993
• The enigma of ifosfamide encephalopathy
  Annals of Oncology, 1992
• Identification of human liver aldehyde dehydrogenases that catalyze the oxidation of aldophosphamide and retinaldehyde
  Biochemical Pharmacology, 1992
• A simple outpatient treatment with oral Ifosfamide and oral Etoposide for patients with small cell lung cancer (SCLC)
  British Journal of Cancer, 1989
• Metabolism of oxazaphosphorines
  Pharmacology & Therapeutics, 1988
• Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention—III. Profile of action of sodium 2-mercaptoethane sulfonate (mesna)
  European Journal of Cancer and Clinical Oncology, 1982